QFINITY on the Steering Committee of the 4th ACDM AI Symposium

Steering Committee am Konferenztisch, goldene Lichtlinie als entstehendes Programm - 4. ACDM KI Symposium

We are very pleased that QFINITY Qualitätsmanagement was represented on the Steering Committee of the 4th Annual Symposium on Artificial Intelligence in Clinical Trials hosted by the ACDM (Association for Clinical Data Management).

Our colleague Marcus Schwabedissen helped shape the program for this major industry event, together with five fellow experts from leading companies:

– Ashley Howard, Pfizer
– Tim Armitage, Medidata Solutions
– Marcus Schwabedissen, QFINITY Qualitätsmanagement
– Rob Nichols, Coronado Research
– Richard Davies, CluePoints
– Robert King, Thermo Fisher Scientific

The Steering Committee curated a strong, forward-looking program with great dedication and expertise, bringing together leading minds from industry, research, and technology to discuss the current state and future of artificial intelligence in clinical trials.

We thank the ACDM for its trust and for the opportunity to play an active part in shaping the symposium – and we look forward to more initiatives around AI and clinical data management.